A New Licensed Quadrivalent Antileptospiral Canine Vaccine Prevents Mortality, Clinical Signs, Infection, Bacterial Excretion, Renal Carriage and Renal Lesions Caused by Leptospira Australis Experimental Challenge
EURICAN<sup>®</sup> L4 was shown to induce quick and long-lasting protection against a severe <i>L.</i> Australis infectious challenge, preventing mortality, clinical signs, infection, bacterial excretion, renal lesions, and renal carriage.
Authors
- Anne-Laure Guiot (ORCID: https://orcid.org/0000-0003-3746-0003)
- Lionel Cupillard
- Frantz Oberli
- J. Bouvet (ORCID: https://orcid.org/0000-0002-2486-727X)
- Carine Cariou
Institutions
- Boehringer Ingelheim (France) (FR)
- École d'Ingénieurs en Chimie et Sciences du Numérique (FR)
Publication Details
- Journal
- Vaccines
- Published
- 2024-09-26
- DOI
- https://doi.org/10.3390/vaccines12101104
- Citations
- 3
- Primary Topic
- Leptospirosis research and findings
- Type
- article
- Field-Weighted Citation Impact
- 1.55